脆弱拟杠菌研究

kai -

国内：

  1. 脆弱拟杆菌的研究进展
  2. 从肠道菌群角度认识阿尔茨海默病的潜在发病机制
  3. 一株无毒脆弱拟杆菌的分离鉴定
  4. 健康婴儿体内的无毒脆弱拟杆菌的分离及鉴定
  5. 脆弱拟杆菌对结直肠疾病的作用以及菌群治疗的展望
  6. 脆弱拟杆菌YCH46在治疗或辅助治疗自身免疫性疾病中的应用
  7. 一种脆弱拟杆菌在预防和/或治疗炎症性肠病中的应用
  8. 一株新型脆弱拟杆菌的安全性评价
  9. 脆弱拟杆菌在制备防治高胆固醇血症组合物中的应用
  10. 脆弱拟杆菌在制备增强吞噬细胞噬菌作用的组合物中的应用
  11. 脆弱拟杆菌提取物在制备防治过敏性皮炎的组合物中的应用
  12. 脆弱拟杆菌在制备抑制艰难梭菌粘附的组合物中的应用
  13. 脆弱拟杆菌YCH46在制备治疗或辅助治疗高血压的药物中的应用（CN201910868766.4）-中国专利【掌桥科研】 (zhangqiaokeyan.com)
  14. 脆弱拟杆菌或阿克曼粘细菌在制备用于预防或治疗肿瘤的药物中的应用（CN201810479187.6）-中国专利【掌桥科研】 (zhangqiaokeyan.com)
  15. APPLICATION OF BACTEROIDES FRAGILIS EXTRACT IN PREPARING DRUG OR FOOD FOR PREVENTING OR TREATING INFLAMMATORY BOWEL DISEASE (zhangqiaokeyan.com)
  16. Altered Behaviour Associated With Autism in a Mouse Model of Fragile X Syndrome Treated With Bacteroides Fragilis BF839
  17. A novel strain of Bacteroides fragilis enhances phagocytosis and polarises M1 macrophages.
  18. 中国人群肠道具有抑制炎症作用的脆弱拟杆菌的分离筛选和功能评价--《江南大学》2020年硕士论文 (cnki.com.cn)
  19. 脆弱拟杆菌抑制阪崎克罗诺杆菌致坏死性小肠结肠炎效果评价及机制研究--《南方医科大学》2019年博士论文 (cnki.com.cn)

国外：

  1. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders
  2. Microbiome: B. fragilis and the brain
  3. Neurodevelopmental disorders: human gut microbiota alleviate behavioural symptoms in a mouse model of autism spectrum disorder
  4. Neurodevelopmental disorders: The gut-microbiome-brain connection
  5. Gut microbiota and brain function: a new target for brain diseases?
  6. Finding a needle in a haystack: Bacteroides fragilis polysaccharide A as the archetypical symbiosis factor 大海捞针，脆弱拟杆菌荚膜是一种典型的共生因子
  7. Next-generation probiotics: the spectrum from probiotics to live biotherapeutics
  8. A microbial symbiosis factor prevents intestinal inflammatory disease
  9. The gut microbiome in neurological disorders
  10. The love–hate relationship between bacterial polysaccharides and the host immune system | Nature Reviews Immunology
  11. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system - PubMed (nih.gov)
  12. Interaction of the Capsular Polysaccharide A from Bacteroides fragilis with DC-SIGN on Human Dendritic Cells is Necessary for Its Processing and Presentation to T Cells - PubMed (nih.gov)
  13. Effect of B7-2 and CD40 signals from activated antigen-presenting cells on the ability of zwitterionic polysaccharides to induce T-Cell stimulation
  14. Bacteroides fragilis–Stimulated Interleukin-10 Contains Expanding Disease | The Journal of Infectious Diseases | Oxford Academic (oup.com)
  15. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota - PubMed (nih.gov)
  16. Exploring the Gut-Brain Axis for the Control of CNS Inflammatory Demyelination: Immunomodulation by Bacteroides fragilis' Polysaccharide A - PubMed (nih.gov)
  17. Commensal microbiota modulation of natural resistance to virus infection (nih.gov)
  18. Sphingolipids from a symbiotic microbe regulate homeostasis of host intestinal natural killer T cells - PubMed (nih.gov)
  19. Plasmacytoid dendritic cells mediate anti-inflammatory responses to a gut commensal molecule via both innate and adaptive mechanisms - PubMed (nih.gov)
  20. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system - PubMed (nih.gov)
  21. Polysaccharide A of Bacteroides fragilis: actions on dendritic cells and T cells - PubMed (nih.gov)